Tag: Emsculpt

All

MedShift and BTL Aesthetics Enter Strategic Partnership for Emsculpt Device

MedShift announces it has entered into a five-year strategic partnership with BTL Corporate. The companies are teaming up to integrate their services to provide a compelling adoption model for Emsculpt, BTL’s body sculpting device.

BTL Files Complaint with the ITC to Prevent the Importing of Products That Infringe on Its Patent
BTL Launches EMSCULPT NEO, a 2-in-1 Solution for Body Contouring Treatments
Body Sculpting Device Maker BTL Settles Counterfeit Lawsuit
The Role of Energy in Male Body Contouring
Emface Treats Wrinkles and Tones Facial Muscles

All

Sorry, No Posts Found

All

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo

If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA
HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors
Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction

Tag: Emsculpt

All

MedShift and BTL Aesthetics Enter Strategic Partnership for Emsculpt Device

BTL Files Complaint with the ITC to Prevent the Importing of Products That Infringe on Its Patent

BTL Launches EMSCULPT NEO, a 2-in-1 Solution for Body Contouring Treatments

Body Sculpting Device Maker BTL Settles Counterfeit Lawsuit

The Role of Energy in Male Body Contouring

Emface Treats Wrinkles and Tones Facial Muscles

All

Sorry, No Posts Found

All

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors

Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links